alexa Abstract | Formulation and Evaluation of Floating Drug Delivery Systems of Propranolol HCl using Modified Pulsincap Technique


Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access

Abstract

Oral controlled release drug delivery systems are one of the promising systems for prolonged duration of action for chronic diseases like hypertension, diabetes etc. Drugs with absorption window in upper GIT (gastro intestinal tract) require special attention for effective therapy. Gastric floating drug delivery systems (GFDDS) are one such suitable delivery system. In our present investigation we attempted to utilize modified pulsincap technique to develop GFDDS of propranolol HCl using PEO WSR 303 polymer. Modified pulsincap technique involve exposing the capsule body to formaldehyde vapors which results in hardening of the shell. The drug- polymer- excipient mixture was filled into the hardened body and covered with untreated cap. All the formulations were evaluated for residual formaldehyde estimation, weight variation, drug content, in-vitro buoyancy, drug release pattern, compatibility studies etc. The formulations F1-4 with drug-polymer ratio 1:0.75 of 1 hr formaldehyde vapour exposure and F2-3 with drug: polymer ratio 1:0.5 of 2 hrs formaldehyde vapour exposure were considered as the optimized formulations as they released 99.99% and 100.00% of the drug in 12 hrs respectively with sufficient buoyancy characteristics. Promising results concluded that the modified pulsincap technique can be successfully used for the development of GFDDS of propranolol HCl using PEO WSR 303.

To read the full article Peer-reviewed Article PDF image

Author(s): GSN Koteswara Rao, KV Ramana Murthy, Aayisha Begum, B Roja Rani, Ch Ragha Naveen, B Raj Kumar, P Uma Devi

Keywords

Formaldehyde, floating capsules, modified pulsincap, propranolol HCl, PEO WSR 303, Liver Inflammation

Recommended Journals

Share This Page

Additional Info

Loading
Loading Please wait..
 
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords